Zealand Pharma A/S (ZEAL.CO) — Technical state
As of 2026-11-16 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 59 out of 100 (momentum 14 · quality 74 · valuation 76), as of 2026-11-18.
- Signal: Stochastic turned down — Its stochastic crossed down from overbought (%K 63.9 under %D 72) 3 sessions ago — momentum is cooling. (as of 2026-11-16)
- Trend: Zealand Pharma A/S trades 4.6% below its 50-day and 20.1% below its 200-day moving average. (as of 2026-11-16)
- Index seat: HALO Growth 100
Zealand Pharma develops peptide-based medicines for gastrointestinal and metabolic conditions, operating from Denmark with a further base in the United States. Its marketed products include an injector treatment for severe low blood sugar and a dual-hormone system pairing insulin with a glucagon-like peptide for an artificial pancreas approach.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ZEAL.CO overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Its stochastic crossed down from overbought (%K 63.9 under %D 72) 3 sessions ago — momentum is cooling.
The moving-average stack
- vs 20-day+2.1%
- vs 50-day-4.6%
- vs 200-day-20.1%
- 52-week band56.9% off the high · +8.7% off the low
- Streak1 consecutive down session
- Stochastic%K 63.9 · %D 72 · down cross
Continue: the ZEAL.CO chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-16
Quick answers
What is the current Closelooknet signal on ZEAL.CO?
Stochastic turned down — Its stochastic crossed down from overbought (%K 63.9 under %D 72) 3 sessions ago — momentum is cooling. As of 2026-11-16; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ZEAL.CO above its 50-day and 200-day moving averages?
As of 2026-11-16, Zealand Pharma A/S trades -4.6% below its 50-day and -20.1% below its 200-day average, with the 20-day +2.1% away.
How far is ZEAL.CO from its 52-week high?
56.9% below the 52-week high and 8.7% above the 52-week low, as of 2026-11-16.
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DECK Deckers Outdoor Corporation
- RACE Ferrari NV
- REGN Regeneron Pharmaceuticals Inc
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- VRSK Verisk Analytics Inc
- DB1.DE Deutsche Börse AG
- FAST Fastenal Company
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- ARGX.BR Argen-Xindustry
- RIGL Rigel Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- SLS Sellas Life Sciences Group Incindustry
- REPL Replimune Group Incindustry